Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Viridian Therapeutics, Inc.\DE (VRDN)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Viridian Therapeutics, Inc.\DE (VRDN) | Chief Financial Officer | $480,000 | $2,642,779 |
| 2024 | Viridian Therapeutics, Inc.\DE (VRDN) | Senior Vice President, Finance and Accounting | $419,600 | $770,659 |
| 2023 | Viridian Therapeutics, Inc.\DE (VRDN) | Senior Vice President, Finance and Accounting | $241,427 | $6,548,526 |
| 2022 | Viridian Therapeutics, Inc.\DE (VRDN) | Senior Vice President, Finance and Accounting | — | — |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.